Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer
J. Anderson(Vanderbilt University), Evan C. Osmundson(Vanderbilt University Medical Center), Alexander D. Sherry(Vanderbilt University), Adam D. Yock(Vanderbilt University Medical Center), Chelsea Anderson(University of North Carolina at Chapel Hill), Neil B. Newman(Vanderbilt University Medical Center)
Cited by 18
Related Papers
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA
|Medical Physics|2016|69
Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences
|Practical Radiation Oncology|2018|67
Initial analysis of the dosimetric benefit and clinical resource cost of CBCT‐based online adaptive radiotherapy for patients with cancers of the cervix or rectum
|Journal of Applied Clinical Medical Physics|2021|59
Online Adaptive Radiation Therapy and Opportunity Cost
|Advances in Radiation Oncology|2022|29